Loading provider…
Loading provider…
Hematology (Internal Medicine) Physician in Albuquerque, NM
NPI: 1316919418Primary Practice Location
UNM HOSPITAL
2211 Lomas Blvd Ne, Albuquerque, NM
Primary Employer
UNM Medical Group - 2211 Lomas
pathology.unm.edu
HQ Phone
Get MD Leslie's Phone Numberphone_androidMobile
Get MD Leslie's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
NM State Medical License
NM State Medical License
2018 - 2025
MO State Medical License
2003 - 2023
OH State Medical License
2006 - 2019
AZ State Medical License
2005 - 2007

American Board of Internal Medicine
Hematology
UTMB Health
utmb.edu
Medical School
Until 1999
Washington University/B-JH/SLCH Consortium
Fellowship • Hematology and Medical Oncology
2001 - 2005
Residency • Internal Medicine
1999 - 2001
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 101 | 227 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 33 | 48 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 11 | 12 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 11 | 11 |
Authors: John Byrd, Farrukh Awan, William Carson
Journal: Blood Adv
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
Authors: John Byrd, Kami Maddocks
Publication Date: 2015-07
Second malignancies in B‐cell chronic lymphocytic leukaemia: possible association with human papilloma virus
Authors: John Byrd
Publication Date: 2010-05
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Azacitidine, DRUG: Sabatolimab
Lead Sponsor: Ohio State University Comprehensive Cancer Center
Collaborators: Hairy Cell Leukemia Foundation
Lead Sponsor: Washington University School of Medicine
Collaborators: National Marrow Donor Program, Predictive BioDiagnostics, LLC